Trevigen 产品代理

产品分类 > 科研试剂 > Trevigen 产品代理

Trevigen 产品代理

2017年9月5日,Bio-Techne自豪地宣布收购Trevigen,Inc.25年来,Trevigen开发了用于生成和分析生理细胞培养模型的创新工具,如类器官、肿瘤球和干细胞衍生细胞系统。这些模型被用于在药物发现、毒理学、再生医学、细胞治疗和癌症研究方面取得重大进展。凭借CultrexTM基底膜基质和CometAssayTM细胞损伤检测等强大品牌,Trevigen产品组合是Bio-Techne的重要补充。它巩固了我们使用2D和3D培养模型为客户提供完整工作流程解决方案的能力,以调查细胞行为和细胞毒性事件。
价格: 0.00

Reagent



On September 5, 2017 Bio-Techne proudly announced its acquisition of Trevigen, Inc. For over 25 years, Trevigen has developed innovative tools for generating and analyzing physiologic cell culture models, such as organoids, tumorspheres, and stem cell-derived cellular systems. These models are being used to make critical advancements in drug discovery, toxicology, regenerative medicine, cell therapy, and cancer research. With strong brands like the CultrexTM Basement Membrane Matrix and the CometAssayTM for cell damage, the Trevigen product portfolio is an important addition to Bio-Techne. It solidifies our ability to offer full workflow solutions to customers using 2D and 3D culture models to investigate cell behavior and cytotoxic events.

 

In the sections below, we outline where you can find the Trevigen products within the Bio-Techne website and how synergies in the Bio-Techne and Trevigen portfolio will benefit scientists across a wide range of research areas.

 

Stem Cell Research

Cell culture matrix substrates are used to expand, maintain, and differentiate pluripotent stem cells in vitro. CultrexTM Basement Membrane Matrix is routinely incorporated into the stem cell culture workflow of the research and development teams at Bio-Techne. It is also a featured component in many of our StemXVivoTM Differentiation Kits and stem cell expansion and differentiation protocols. We have utilized the Cultrex portfolio because we believe in the quality and consistency that it provides for our stem cells. Having the full Trevigen portfolio integrated with Bio-Techne allows us to provide a broader offering of high quality culture reagents to the stem cell community. Check out our full portfolio of Stem Cell Reagents.